|
1
|
Gubler MC: Inherited diseases of the
glomerular basement membrane. Nat Clin Prac Nephrol. 4:24–37.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hudson BG, Tryggvason K, Sundaramoorthy M
and Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type
IV collagen. N Engl J Med. 348:2543–2556. 2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Alport AC: Hereditary familial congenital
haemorrhagic nephritis. Br Med J. 1:504–506. 1927.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Han KH, Park JE and Ki CS: De novo
mutations in COL4A5 identified by whole exome sequencing in 2 girls
with Alport syndrome in Korea. Korean J Pediatr. 62:193–197.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Behjati S and Tarpey PS: What is next
generation sequencing? Arch Dis Child Educ Pract Ed. 98:236–238.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wei G, Zhihong L, Huiping C, Caihong Z,
Zhaohong C and Leishi L: Spectrum of clinical features and type IV
collagen alpha-chain distribution in Chinese patients with Alport
syndrome. Nephrology, dialysis, transplantation: Official
publication of the European Dialysis and Transplant Association.
European Renal Association. 21:3146–3154. 2006.
|
|
7
|
Barker DF, Hostikka SL, Zhou J, Chow LT,
Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL and
Tryggvason K: Identification of mutations in the COL4A5 collagen
gene in Alport syndrome. Science. 248:1224–1227. 1990.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kashtan CE: Alport syndromes: Phenotypic
heterogeneity of progressive hereditary nephritis. Pediatr Nephrol.
14:502–512. 2000.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Meleg-Smith S, Magliato S, Cheles M,
Garola RE and Kashtan CE: X-linked Alport syndrome in females. Hum
Pathol. 29:404–408. 1998.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jais JP, Knebelmann B, Giatras I, De
Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO,
Flinter F, et al: X-linked Alport syndrome: Natural history and
genotype-phenotype correlations in girls and women belonging to 195
families: A ‘European community Alport syndrome concerted action’
study. J Am Soc Nephrol. 14:2603–2610. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tsiakkis D, Pieri M, Koupepidou P,
Demosthenous P, Panayidou K and Deltas C: Genotype-phenotype
correlation in X-linked Alport syndrome patients carrying missense
mutations in the collagenous domain of COL4A5. Clin Genet.
82:297–299. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhao X, Chen C, Wei Y, Zhao G, Liu L, Wang
C Zhang J and Kong X: Novel mutations of COL4A3, COL4A4, and COL4A5
genes in Chinese patients with Alport syndrome using next
generation sequence technique. Mol Genet Genomic Med.
7(e653)2019.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American College
of Medical Genetics and Genomics and the Association for Molecular
Pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang YF, Ding J, Wang F and Bu DF: Effect
of glycine substitutions on alpha5(IV) chain structure and
structure-phenotype correlations in Alport syndrome. Biochem
Biophys Res Commun. 316:1143–1149. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hudson BG: The molecular basis of
Goodpasture and Alport syndromes: Beacons for the discovery of the
collagen IV family. J Am Soc Nephrol. 15:2514–2527. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kashtan CE: Alport Syndrome and thin
basement membrane nephropathy. In: Adam MP, Ardinger HH, Pagon RA,
Wallace SE, Bean LJH, Stephens K, et al, editors.
GeneReviews((R)). Seattle (WA) 1993.
|
|
17
|
Slajpah M, Gorinsek B, Berginc G, Vizjak
A, Ferluga D, Hvala A, Meglic A, Jaksa I, Furlan P, Gregoric A, et
al: Sixteen novel mutations identified in COL4A3, COL4A4, and
COL4A5 genes in Slovenian families with Alport syndrome and benign
familial hematuria. Kidney Int. 71:1287–1295. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Demosthenous P, Voskarides K, Stylianou K,
Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P,
Stavrou C, Daphnis E, et al: X-linked Alport syndrome in Hellenic
families: Phenotypic heterogeneity and mutations near interruptions
of the collagen domain in COL4A5. Clin Genet. 81:240–248.
2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xiu X, Yuan J, Deng X, Xiao J, Xu H, Zeng
Z, Guan L, Xu F and Deng S: A novel COL4A5 mutation identified in a
Chinese Han family using exome sequencing. Biomed Res Int.
2014(186048)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Morinière V, Dahan K, Hilbert P, Lison M,
Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E,
et al: Improving mutation screening in familial hematuric
nephropathies through next generation sequencing. J Am Soc Nephrol.
25:2740–2751. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhou J, Hertz JM and Tryggvason K:
Mutation in the alpha 5(IV) collagen chain in juvenile-onset Alport
syndrome without hearing loss or ocular lesions: Detection by
denaturing gradient gel electrophoresis of a PCR product. Am J Hum
Genet. 50:1291–1300. 1992.PubMed/NCBI
|
